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Introduction. According to the 2016 World Health Organization classification of Tumors of the Central Nervous System, the term
Primitive Neuroectodermal Tumor has been replaced by the term Embryonal Tumor (ET). We present a case of disseminated
cerebrospinal ET presenting in an adult patient. Illustrative Case. A 49-year-old male presenting with low back pain, dysuria,
and hypoesthesia of the lower extremities referred to our emergency department. Brain and whole spine contrast-enhanced MRI
documented a diffusively disseminated heterogeneous neoplasm with intradural extra- and intramedullary involvement of the
cervicothoracic tract and cauda equina. A primary biopsy of the lumbosacral localization was performed through L5 bilateral
laminectomy. Histologic diagnosis was Embryonal Tumor Not Otherwise Specified. The patient underwent chemotherapy with
postoperative adjuvant alternating Vincristine-Doxorubicin-Ifosfamide (VAI) and Ifosfamide-Etoposide (IE). Discussion. Spinal
ETs are exceedingly rare especially when presenting in the adult patient. Neurosurgical and oncologic management is still unclear.
When feasible, surgical removal should always be performed to obtain a histologic diagnosis. Postoperative adjuvant therapymight
entail both chemo- and radiotherapy; however a consensus on this matter is still lacking.
1. Introduction
According to the 2016 World Health Organization (WHO)
Tumors of the Central Nervous System (CNS) classification,
the term “Primitive Neuroectodermal Tumors (PNETs)” has
been removed from the diagnostic lexicon. A newly defined
category of CNS tumors, including PNETs among other
nosological entities, according to the old nomenclature, has
been introduced under the term Embryonal Tumors (ETs)
[1]. The presence of amplification of the 19q13.42 region on
chromosome 19 (C19MC) differentiates between Embryonal
Tumors with Multilayered Rosettes (ETMR), C19MC altered,
and ETMR, C19MC nonaltered, or Not Otherwise Specified
(NOS). ETs are malignant small, highly cellular neoplasms
occurring predominantly in children, rarely in adults. The
most common localization of the disease is the cerebellum
(medulloblastomas) accounting for 20–25% of all pediatric
brain tumors [2]. ETs primarily occur in children and young
adults, usually before the fourth decade, with a mean age
of 20 years. ETs are described as arising also in the pineal
region, cortex, brain stem, and peripheral nerves in adults.
A primary intraspinal ET is rare; the mainstay of therapy is
a surgical resection whenever feasible followed by chemo-
and radiotherapy; a consensus regarding the most adequate
adjuvant treatment protocol is not available up to the present
date [3].
Intraspinal ETs are rapid-growing soft tissue masses,
which cause symptoms of nerve compression, ranging from
radiculopathy to sphincter dysfunction, and pain. They are
highly malignant and invasive, with a high rate of relapse,
and retain a poor prognosis.The five-year survival rate is 30–
40% and the median survival ranges from 12 to 24 months;
prognosis of these tumors in adults is somewhat worse when
diagnosed in adults [3–5].
We report one case of a diffuse ET with brain and spinal
dissemination in a 49-year-old male presenting with low
back pain, numbness of the lower extremities, and sphinc-
ter dysfunction which represented not only a diagnostic
dilemma given its aspecific clinical presentation and peculiar
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Figure 1: Contrast-enhanced T1- and T2-weighted brain MRI sequences showing contrast enhancing infracentimetric nodules of both
temporopolar regions (line (a)) and of the brainstem (line (b)) (white arrow).
radiological features but also, and most importantly, a ther-
apeutic challenge given the lack of consensus regarding its
management.
2. Illustrative Case
A 49-year-old man presented to our emergency department
in October 2015, describing numbness of the lower extrem-
ities and low back pain developed during the previous two
weeks. Furthermore, he complained of dysuria during the
last few days and progressive subjective wasting of lower
limbs muscles over the last months. Patient family history
and general physical examination did not provide any con-
tributive information. Neurologic examination confirmed a
diffuse hypotrophy of lower limbs muscles, without any focal
motor deficit and associated with hypoesthesia of the sciatic
territory bilaterally.
A brain MRI (Figure 1) showed multiple infracentimetric
corticosubcortical nodular lesions of temporopolar regions
bilaterally of themedulla oblongata, cerebellar tonsils, and left
cerebellar hemisphere which appeared hyperintense on T2-
weighted sequences and presented a homogenous enhance-
ment on T1 contrast-enhanced sequences. A whole spine
MRI (Figure 2) documented a diffuse leptomeningeal con-
trastografic enhancement with numerous irregularly shaped
intra and extramedullary lesions of the midcervical to cer-
vicothoracic junction and lumbosacral tracts, correspond-
ing to a diffuse medullary hyperintensity on T2-weighted
sequences. The roots of the cauda equina were enlarged with
signal alteration on both T2-weighted and contrast-enhanced
sequences suggesting diffuse neoplastic infiltration. A spec-
troscopic analysis performed on the left cerebellar subcortical
lesion showed peaks of lipid/lactate, reduction of N-acetyl-
aspartate (NAA), and increase in choline (CHO) suggesting
a discariocinetic injury.
A cerebrospinal fluid (CSF) sample was collected; how-
ever no neoplastic cells were documented on cytological ex-
amination.
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Figure 2: Contrast-enhanced T1- (a) and T2-weighted (b) whole
spine MRI sequences showing disseminated intradural intra- and
extramedullary Embryonal Tumor of the cervicothoracic tract and
cauda equina.
The patient underwent a primary biopsy on the lum-
bosacral localization which appeared to enlarge the S1-S2
posterior sacral foramen causing compression of the right S2
nerve root. Using a posterior approach, a central L5 laminec-
tomy along with median durotomy was performed exposing
a grey, soft, hemorrhagic mass which completely enveloped
the roots of the cauda equina.
Tissues samples were collected for histological examina-
tion.
Patient was discharged on the ninth postoperative day
and referred to our oncologic unit. Chemotherapy with alter-
nating Vincristine-Doxorubicin-Ifosfamide (VAI) and Ifos-
famide-Etoposide (IE) was the adjuvant treatment protocol
of choice which the patient is currently undertaking with a
satisfying profile of tolerability.
3. Histological Examination
Intraoperative smear cytopathological examination showed a
“small blue cell” neoplasm, composed of sheets of discohe-
sive undifferentiated, hyperchromatic cells, with occasional
evidence of Homer Wright rosette formation. Histological
examination on formalin-fixed, paraffin-embedded sections
revealed a highly cellular neoplasm composed of small- to
medium-sized cells with little perinuclear cytoplasm and
hyperchromatic nuclei with granular chromatin. Mitoses
were frequent, as was necrosis of single tumor cells. Immuno-
histochemistry showed an intense and diffuse positivity for
Neural Cell Adhesion Molecule (N-CAM) and a slightly less
intense, but almost equally diffuse positivity for glial fibrillary
acid protein (GFAP). Expression of protein INI1 was detected
while LIN28 was not detected; moreover no amplification of
19q13.42 was detected. These features allowed excluding both
an Atypical Teratoid Rhabdoid Tumor (AT/RT) and Embry-
onal TumorwithMultilayeredRosettes (ETMR), respectively.
Proliferation index was high (Ki-67 over 40%). Reactions
with antibodies against synaptophysin, keratin, and epithelial
membrane antigen (EMA) were negative in all tumor cells
(Figure 3).
According to the old WHO classification of Tumors of
CNS, this tumor could be categorized as a PNET of central
origin; however, since the introduction of the 2016 classifica-
tion, this lesion could not be defined neither as a PNET (the
latter being completely removed from current classifications)
nor as the newly defined Embryonal Tumors with Multilay-
ered Rosettes (ETMR), leaving the Embryonal Tumor Not
Otherwise Specified (NOS) as the sole diagnostic option.
4. Discussion
The term Primitive Neuroectodermal Tumor (PNET) was
created in 1973 by Hart and Earle to describe predominantly
undifferentiated tumors of the cerebrum which contained
90–95% of undifferentiated cells not meeting diagnostic
criteria for other tumor entities [6]. First case of PNET dates
back to 1969 [7]. Ten years later, Rorke, Becker, and Hinton
independently advocated that all central nervous system
tumors predominantly composed of primitive neuroepithe-
lial cells should be called PNETs [8, 9]. According to the
World Health Organization classification of Tumors of the
CentralNervous System, renewed in 2016, the termPNETs no
longer exists. All PNETs are to be categorized under the term
Embryonal Tumor (ET) including Embryonal Tumors with
Multilayered Rosettes (ETMR), Atypical Teratoid Rhabdoid
Tumor (AT/RT), and Not Otherwise Specified (NOS) [1].
Primary spinal ETs are more frequently observed in
infants, children, and young adults (age range 1 to 70 years;
mean 22.5 years). The duration of symptoms, initially entail-
ing radiculopathy and paresthesia, may range from one week
to six months. Most cases of primary spinal ETs, according to
the old classification, retain a peripheral origin (expression
of CD99) and rarely present a central origin (CD99 not
expressed). Despite being extremely useful for differentiating
between ETs of central or peripheral origin, the expression
of CD99 should always be associated with the research of (11;
22) (q24; q12) translocation, which is diagnostic for ETs of
peripheral origin typically related to Ewing sarcoma [3].
Imaging features are nonspecific, including intradural
intra- and/or extramedullary more or less diffuse lesions
showing heterogeneous patterns of contrast enhancement
(including diffuse leptomeningeal enhancement), central
necrosis, and hemorrhage.Themainstay of treatment is surgi-
cal resection; however, this is uncommonly feasible due to the
multifocal extensive dissemination of the disease which is not
uncommon at presentation.The adjuvant treatment protocol
should include a combination of chemo- and radiotherapy;
however a consensus on this subject is still lacking due
to the exceeding rarity of the disease preventing drawing
meaningful conclusions on the basis of the currently available
short case-series or single case reports in the literature.
Most cases of ETs involving the spinal cord are “drop”
metastases from primary intracranial tumors. Our patient




Figure 3: (a) Neoplastic cells show diffuse and strong immunoreactivity for synaptophysin; (b-c) high proliferation activity is highlighted by
many Ki-67 immunoreactive tumor cell nuclei. (d) H&E image of a highly cellular neoplasm, composed of small- to medium-sized cells with
hyperchromatic nuclei and little cytoplasm; rosette formation is rarely seen; mitotic figures and necrosis of individual tumor cells are typical
features. (e) Focal glial fibrillary acid protein (GFAP) immunoreactivity in individual cells; many tumor cells are negative.
showed an extremely diffuse spinal disease with few intracra-
nial nodules (Figures 1 and 2), a figure normally associated
with aworst prognosis. Inmost patients cited in the literature,
spinal localization involved the cauda equina with a single
report of supratentorial dissemination. ETs of central origin
such as our case are rare proliferative and highly aggres-
sive neoplasms. Their presentation in the adult with major
involvement of the intradural extramedullary compartment
is extremely rare. Spinal cord compression or cauda equina
causes the symptoms that lead to diagnosis. To date, a spinal
ETwith diffuse cervicothoracic-lumbosacral and intracranial
dissemination was never reported.
According to our experience, an open-field biopsy of the
lumbosacral spine localization was the least risky method to
obtain a histological diagnosis in this specific case consid-
ering both the reduced size of brain multifocal nodules and
the unforeseeable risk of hemorrhagic complications of any
needle biopsy procedure.
Case reporting, for such rare nosological entity, may
be extremely useful not only for further understanding of
Embryonal Tumors but also for providing evidences for
future reviews aiming to define a consensus regarding the
therapeutic management of this malignant disease.
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